Ergothioneine

Ergothioneine is a small, water-soluble molecule classified as a thione-containing derivative of the amino acid histidine, carrying a sulfur atom on its imidazole ring ^[1][4]. Unusually for a sulfur compound, it resists oxidation by air and exists largely in a form that is less chemically reactive than typical thiols such as glutathione ^[4]. It was first isolated in 1909 by the French chemist Charles Tanret from the ergot fungus, which is the source of its name, and its structure was worked out a few years later ^[4].

Only a limited set of organisms can manufacture ergothioneine, chiefly certain fungi, actinobacteria such as mycobacteria, and cyanobacteria; the pathway begins by methylating histidine and then incorporates sulfur derived from cysteine ^[4]. Animals and humans cannot make it and must obtain it from food, with mushrooms, particularly oyster and bolete species, being the richest dietary sources, alongside smaller amounts in organ meats, beans, and grains ^[1][4]. Once ingested, it is taken up and concentrated inside cells by a dedicated transporter known as OCTN1, encoded by the gene SLC22A4, and it builds up in tissues such as red blood cells, bone marrow, liver, kidney, and the eyes ^[1][4].

The existence of a specific, high-affinity transporter that concentrates ergothioneine in the body has led researchers to suspect it serves a beneficial physiological role, even though that role has not been definitively pinned down ^[1][2]. Laboratory studies have repeatedly shown that ergothioneine can neutralize reactive oxygen species and shield cells from various forms of oxidative and chemical stress, and one influential hypothesis frames its accumulation in injured tissues as an adaptive, protective response ^[1][2]. Low blood levels have been associated in some studies with age-related disease, prompting the proposal that ergothioneine be regarded as a "longevity vitamin," a dietary compound that may not be essential for immediate survival but could help protect long-term health ^[3]. Firm evidence for clinical benefit in humans nonetheless remains preliminary ^[1][3].

Ergothioneine is sold as a dietary supplement, and biotechnology methods using engineered microbes have been developed to produce it at scale ^[4]. Food-safety authorities in Europe have assessed synthesized ergothioneine and set intake levels considered safe ^[4]. Related compounds include the selenium-containing analog selenoneine, which is made by the same biosynthetic machinery when selenium is present ^[4].

Ergothioneine has an excellent safety profile with no significant toxicity reported even at high intakes. It's naturally present in the diet, especially in mushrooms, and is well tolerated as a supplement. Because outcome data in humans is still early, benefits should be viewed as promising rather than proven.